Bi Asset Management Fondsmaeglerselskab A United Therapeutics Corp Transaction History
Bi Asset Management Fondsmaeglerselskab A
- $10.2 Billion
- Q2 2025
A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in United Therapeutics Corp stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 40,600 shares of UTHR stock, worth $18.4 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
40,600
Previous 83,866
51.59%
Holding current value
$18.4 Million
Previous $25.9 Million
54.88%
% of portfolio
0.11%
Previous 0.29%
Shares
15 transactions
Others Institutions Holding UTHR
# of Institutions
745Shares Held
44.1MCall Options Held
340KPut Options Held
318K-
Black Rock Inc. New York, NY5.47MShares$2.48 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$2.02 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$1.07 Billion12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$982 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$961 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $20.6B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...